PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000976124.84505.49 |
| _version_ | 1797280129410400256 |
|---|---|
| author | Yuqin Song Helen Wu Meng Ji Wenhan Jiang Cassie Dong Jun Zhu |
| author_facet | Yuqin Song Helen Wu Meng Ji Wenhan Jiang Cassie Dong Jun Zhu |
| author_sort | Yuqin Song |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:35:51Z |
| format | Article |
| id | doaj.art-cf78128b5d6b4b5caf20a80644dba757 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:35:51Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-cf78128b5d6b4b5caf20a80644dba7572024-03-03T09:43:43ZengWileyHemaSphere2572-92412023-08-017e845054910.1097/01.HS9.0000976124.84505.49202308003-02205PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMASYuqin Song0Helen Wu1Meng Ji2Wenhan Jiang3Cassie Dong4Jun Zhu51 Peking University Cancer Hospital and Institute,, Beijing, China, Department of Lymphoma, Beijing, China2 Takeda Development Center Asian, Shanghai, China, Shanghai, China2 Takeda Development Center Asian, Shanghai, China, Shanghai, China2 Takeda Development Center Asian, Shanghai, China, Shanghai, China3 Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA, Lexington, MA, USA, United States1 Peking University Cancer Hospital and Institute,, Beijing, China, Department of Lymphoma, Beijing, Chinahttp://journals.lww.com/10.1097/01.HS9.0000976124.84505.49 |
| spellingShingle | Yuqin Song Helen Wu Meng Ji Wenhan Jiang Cassie Dong Jun Zhu PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS HemaSphere |
| title | PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title_full | PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title_fullStr | PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title_full_unstemmed | PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title_short | PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title_sort | pb2351 trial in progress a phase 2 multicentre study of brentuximab vedotin with chemotherapy in frontline treatment of chinese patients with cd30 positive peripheral t cell lymphomas |
| url | http://journals.lww.com/10.1097/01.HS9.0000976124.84505.49 |
| work_keys_str_mv | AT yuqinsong pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas AT helenwu pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas AT mengji pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas AT wenhanjiang pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas AT cassiedong pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas AT junzhu pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas |